INJECTION
THE RISE OF LARGE-VOLUME SC ADMINISTRATION OF BIOPHARMACEUTICALS, AND DELIVERY IMPLICATIONS
Ypsomed's Andreas Schneider and Jakob Lange consider the SC administration of larger volumes of biopharmaceuticals in the pharmaceutical industry and summarise a recent study that reviews clinical-stage and approved IV and SC biopharmaceuticals to provide valuable guidance for new product development, as well as for marketing and commercialisation strategies in the rapidly evolving large-volume SC landscape.